Search Results for "Pexeva"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Pexeva. Results 1 to 4 of 4 total matches.
See also: paroxetine

Paroxetine (Brisdelle) for Hot Flashes

   
The Medical Letter on Drugs and Therapeutics • Oct 28, 2013  (Issue 1428)
(Pexeva) and paroxetine hydrochloride (Paxil, and generics) are marketed in higher doses for treatment ...
The FDA has approved a low-dose formulation of the selective serotonin reuptake inhibitor (SSRI) paroxetine mesylate (Brisdelle – Noven Therapeutics) for treatment of moderate-to-severe vasomotor symptoms associated with menopause. It is the first non-hormonal therapy to be approved for this indication. Paroxetine mesylate (Pexeva) and paroxetine hydrochloride (Paxil, and generics) are marketed in higher doses for treatment of depression and other psychiatric disorders.
Med Lett Drugs Ther. 2013 Oct 28;55(1428):85-6 |  Show IntroductionHide Introduction

Vilazodone (Viibryd) - A New Antidepressant

   
The Medical Letter on Drugs and Therapeutics • Jul 11, 2011  (Issue 1368)
20 mg once 190.98 Pexeva (Synthon) Sertraline – generic 25, 50, 100 mg tabs; 50-100 mg once 50-200 ...
Vilazodone (Viibryd – Forest), a selective serotonin reuptake inhibitor (SSRI) and partial 5-HT1A receptor agonist, has been approved by the FDA for treatment of depression. It has been claimed to have no sexual side effects and not to cause weight gain.
Med Lett Drugs Ther. 2011 Jul 11;53(1368):53-4 |  Show IntroductionHide Introduction

Extended-Release Fluvoxamine (Luvox CR)

   
The Medical Letter on Drugs and Therapeutics • Jun 30, 2008  (Issue 1289)
controlled release – 25 mg once 113.40 Paxil CR — + Paroxetine mesylate – + — 40 mg once 150.00 Pexeva ...
Fluvoxamine maleate, a selective serotonin reuptake inhibitor (SSRI) that has been available for many years in an immediate-release formulation (Luvox, and others) for treatment of obsessive-compulsive disorder (OCD) in children and adults, has now been approved by the FDA in an extended-release formulation (Luvox CR - Jazz Pharmaceuticals) for treatment of OCD and social anxiety disorder (SAD) in adults.
Med Lett Drugs Ther. 2008 Jun 30;50(1289):50-1 |  Show IntroductionHide Introduction

Desvenlafaxine for Depression

   
The Medical Letter on Drugs and Therapeutics • May 19, 2008  (Issue 1286)
Pexeva (Synthon) 10, 20, 30, 40 mg tabs 10 mg once 20 mg once 137.10 Sertraline – Zoloft (Pfizer) 25, 50 ...
The FDA has approved the marketing of desvenlafaxine (Pristiq - Wyeth), the main active metabolite of venlafaxine (Effexor, and others - Wyeth), for treatment of major depressive disorder. Venlafaxine, a norepinephrine and serotonin reuptake inhibitor (SNRI), is available generically as an immediate-release tablet. Venlafaxine extended-release capsules (Effexor XR) are scheduled to go off-patent in 2010.
Med Lett Drugs Ther. 2008 May 19;50(1286):37-9 |  Show IntroductionHide Introduction